Ardent Health Statistics
Total Valuation
Ardent Health has a market cap or net worth of $1.39 billion. The enterprise value is $3.07 billion.
| Market Cap | 1.39B |
| Enterprise Value | 3.07B |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ardent Health has 143.35 million shares outstanding. The number of shares has increased by 3.91% in one year.
| Current Share Class | 143.35M |
| Shares Outstanding | 143.35M |
| Shares Change (YoY) | +3.91% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 20.96% |
| Float | 24.14M |
Valuation Ratios
The trailing PE ratio is 10.24 and the forward PE ratio is 8.14. Ardent Health's PEG ratio is 2.03.
| PE Ratio | 10.24 |
| Forward PE | 8.14 |
| PS Ratio | 0.22 |
| Forward PS | 0.21 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 3.78 |
| P/FCF Ratio | 6.40 |
| P/OCF Ratio | 3.21 |
| PEG Ratio | 2.03 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.13, with an EV/FCF ratio of 14.10.
| EV / Earnings | 22.89 |
| EV / Sales | 0.48 |
| EV / EBITDA | 6.13 |
| EV / EBIT | 9.06 |
| EV / FCF | 14.10 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 1.32.
| Current Ratio | 2.12 |
| Quick Ratio | 1.40 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 10.51 |
| Interest Coverage | 6.38 |
Financial Efficiency
Return on equity (ROE) is 13.94% and return on invested capital (ROIC) is 8.11%.
| Return on Equity (ROE) | 13.94% |
| Return on Assets (ROA) | 4.17% |
| Return on Invested Capital (ROIC) | 8.11% |
| Return on Capital Employed (ROCE) | 7.89% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $255,118 |
| Profits Per Employee | $5,328 |
| Employee Count | 25,200 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 22.16 |
Taxes
In the past 12 months, Ardent Health has paid $57.09 million in taxes.
| Income Tax | 57.09M |
| Effective Tax Rate | 19.91% |
Stock Price Statistics
The stock price has decreased by -25.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.84% |
| 50-Day Moving Average | 9.53 |
| 200-Day Moving Average | 10.26 |
| Relative Strength Index (RSI) | 56.73 |
| Average Volume (20 Days) | 708,018 |
Short Selling Information
The latest short interest is 3.63 million, so 2.54% of the outstanding shares have been sold short.
| Short Interest | 3.63M |
| Short Previous Month | 2.88M |
| Short % of Shares Out | 2.54% |
| Short % of Float | 15.06% |
| Short Ratio (days to cover) | 6.08 |
Income Statement
In the last 12 months, Ardent Health had revenue of $6.43 billion and earned $134.28 million in profits. Earnings per share was $0.95.
| Revenue | 6.43B |
| Gross Profit | 3.77B |
| Operating Income | 339.41M |
| Pretax Income | 286.75M |
| Net Income | 134.28M |
| EBITDA | 501.89M |
| EBIT | 339.41M |
| Earnings Per Share (EPS) | $0.95 |
Balance Sheet
The company has $611.22 million in cash and $2.29 billion in debt, giving a net cash position of -$1.68 billion or -$11.71 per share.
| Cash & Cash Equivalents | 611.22M |
| Total Debt | 2.29B |
| Net Cash | -1.68B |
| Net Cash Per Share | -$11.71 |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 9.34 |
| Working Capital | 1.07B |
Cash Flow
In the last 12 months, operating cash flow was $435.08 million and capital expenditures -$217.08 million, giving a free cash flow of $217.99 million.
| Operating Cash Flow | 435.08M |
| Capital Expenditures | -217.08M |
| Depreciation & Amortization | 162.49M |
| Net Borrowing | -3.35M |
| Free Cash Flow | 217.99M |
| FCF Per Share | $1.52 |
Margins
Gross margin is 58.60%, with operating and profit margins of 5.28% and 2.09%.
| Gross Margin | 58.60% |
| Operating Margin | 5.28% |
| Pretax Margin | 4.46% |
| Profit Margin | 2.09% |
| EBITDA Margin | 7.81% |
| EBIT Margin | 5.28% |
| FCF Margin | 3.39% |
Dividends & Yields
Ardent Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.91% |
| Shareholder Yield | -3.91% |
| Earnings Yield | 9.63% |
| FCF Yield | 15.63% |
Analyst Forecast
The average price target for Ardent Health is $12.41, which is 27.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.41 |
| Price Target Difference | 27.54% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 4.45% |
| EPS Growth Forecast (3Y) | -1.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ardent Health has an Altman Z-Score of 2.11 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.11 |
| Piotroski F-Score | 7 |